Shilpa Medicare · NSE: SHILPAMED · BSE: 530549

Q1 FY26 results · Apr–Jun 2025

Shilpa Medicare reported revenue from operations of ₹321.46 crore (up 9.9% from Q1 FY25) and net profit of ₹46.89 crore (up 233.4% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue from operations321.46292.51+9.9%330.80−2.8%
Other income6.389.44−32.4%7.57−15.8%
Total income327.84301.95+8.6%338.38−3.1%
Profit before share of associates & JVs and tax50.3132.20+56.3%12.98+287.7%
Share of profit/(loss) of associates & JVs(0.73)(3.52)2.30
Net profit for the period46.8914.06+233.4%14.51+223.1%
EPS, basic (₹)4.791.46+228.1%1.48+223.6%
Net margin (%)14.64.84.4

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue from operations92.4396.12−3.8%126.15−26.7%
Other income17.7931.45−43.4%14.08+26.3%
Total income110.22127.57−13.6%140.24−21.4%
Profit before tax14.7940.69−63.7%(9.43)Turned profit
Net profit for the period20.7028.35−27.0%(5.15)Turned profit
EPS, basic (₹)2.122.94−27.9%(0.53)Turned profit
Net margin (%)22.429.5-4.1
Consolidated
Filed with BSE
13 Aug 2025, 18:30 IST
Board meeting
13 Aug 2025
Period
01 Apr 2025 to 30 Jun 2025
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Aug 2025, 18:30 IST
Board meeting
13 Aug 2025
Period
01 Apr 2025 to 30 Jun 2025
Review status
Unaudited
Source
XBRL filing on BSE